Zai Lab (ZLAB) Asset Writedowns and Impairment (2020 - 2026)
Zai Lab (ZLAB) posted Asset Writedowns and Impairment of $188000.0 for Q1 2026, down 98.35% sequentially from $11.4 million in Q4 2025, and up 596.3% YoY from $27000.0 in Q1 2025.
Analysis
Zai Lab (ZLAB) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Zai Lab has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $188000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 596.3% year-over-year to $188000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (up 1446.46% YoY) and the FY2025 annual result came in at $12.3 million, up 1407.73% from the prior year.
- Asset Writedowns and Impairment eased to $188000.0 in Q1 2026 per ZLAB's latest filing, from $11.4 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $11.4 million in Q4 2025 and troughed at -$3000.0 in Q4 2022.
- A 5-year average of $867117.6 and a median of $188000.0 in 2026 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment tumbled 100.31% in 2022, then jumped 1136800.0% in 2025.
- Over 5 years, Asset Writedowns and Impairment stood at -$3000.0 in 2022, then jumped by 7666.67% to $227000.0 in 2023, then sank by 99.56% to $1000.0 in 2024, then surged by 1136800.0% to $11.4 million in 2025, then slumped by 98.35% to $188000.0 in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $188000.0, $11.4 million, and $625000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.89 Mn |
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 11.37 Mn |
| Sep 30, 2025 | 625,000.00 |
| Jun 30, 2025 | 267,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 719,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 227,000.00 |
| Sep 30, 2023 | 123,000.00 |
| Jun 30, 2023 | 246,000.00 |
| Mar 31, 2023 | 377,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 287,000.00 |
| Jun 30, 2022 | 55,000.00 |
| Mar 31, 2022 | 138,000.00 |
| Dec 31, 2021 | 966,000.00 |
| Sep 30, 2021 | 112,000.00 |